Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives
作者:Kaan Birgül、Yeliz Yıldırım、H. Yeşim Karasulu、Ercüment Karasulu、Abdullah Ibrahim Uba、Kemal Yelekçi、Hatice Bekçi、Ahmet Cumaoğlu、Levent Kabasakal、Özgür Yılmaz、Ş. Güniz Küçükgüzel
DOI:10.1016/j.ejmech.2020.112841
日期:2020.12
and compounds 5g, 5m and 5n exhibited anticancer activity against LNCaP cell lines 12.25, 22.76 and 2.21 μM, respectively. Consequently, of these results, compounds 5e and 5n showed the highest activities against androgen dependent and independent prostate cancer cell lines, so these compounds could be potent small molecules against prostate cancer. Furthermore, mitogen-activated protein kinase (MAPK)
在这项研究中,合成了(S)-萘普生硫代氨基脲(3a-d),1,2,4-三唑(4a-c),三唑-硫醚杂化化合物(5a-p)及其结构(3a,3d,4a和图5a-p )通过FT-IR,确认1 H NMR,13 C NMR,HR-质谱和元素分析。这些化合物旨在抑制前列腺癌中的蛋氨酸氨基肽酶2(MetAP2)酶。通过使用MTS方法评估了这些化合物(3d,5a-p)对雄激素非依赖性前列腺腺癌(PC-3,DU-145)和雄激素非依赖性前列腺腺癌(LNCaP)细胞系的影响。化合物5a,图5b,5d和5e显示了对PC-3细胞系的14.2、5.8、10.8和8.4μM抗癌活性,化合物5e,5g和5n表现出对DU-145细胞系18.8、12.25和10.2μM的抗癌活性,以及化合物5g,5m 5n和5n分别对LNCaP细胞系12.25、22.76和2.21μM具有抗癌活性。因此,在这些结果中,化合物5e和5